Controlling the temperature of your experiment standardizes the testing environment and reduces outside influences. Both QPatch and Qube now feature the ability to control the temperature enabling experiments to be performed at physiological temperatures.
Due to the risk of the fatal arrhythmia Torsade de Pointes, all drug candidates are tested for their potential modulation of the cardiac ion channel hERG. Some hERG-blockers are more potent at physiological temperatures than at lower temperatures, and their potency may, therefore, be underestimated when tested at room temperature.

Read moreless about the QPatch温度コントロールユニット